ReviewBMC neurology2026
A type IV spinal muscular atrophy with gastrocnemius pseudohypertrophy caused by SMN1 deletion: a case report and literature review.
Review in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundSpinal muscular atrophy (SMA) is a rare autosomal recessive genetic disorder characterized by severe neurological and muscular degeneration, often leading to severe disability or death. Its complex clinical manifestations frequently result in misdiagnosis or missed diagnosis. Type IV SMA primarily affects adults, rarely impacting normal lifespan or maximum motor capacity, and is clinically uncommon. However, SMA presenting with pseudohypertrophy of the gastrocnemius muscle and near-complete loss of motor function is extremely rare and has not been previously reported. We hereby report what we believe to be the first case of Type IV SMA caused by SMN1 deletion presenting with pseudohypertrophy of the gastrocnemius muscle. CASE PRESENTATION: A 51-year-old man presented with progressive weakness in all four limbs over 16 years, which worsened over the past two months, leaving him unable to walk. Examination strongly suggested a diagnosis of SMA type IV. He was found to have a homozygous deletion of the SMN1 gene at exon 7, located on 5q13.2. Muscle strength in the biceps brachii and triceps brachii of both upper limbs was grade IV, with weakened grip strength in both hands. Grade III muscle strength in the quadriceps of both lower limbs, Grade IV muscle strength in the tibialis anterior, gastrocnemius, and extensor hallucis longus muscles, bilateral knee reflexes and Achilles reflexes (+), right Hoffmann’s sign (+), bilateral Babinski signs (+), and Gower’s sign (+). Multiple disc herniations with degeneration in the cervical spine. Multiple muscle atrophy of the thoracic wall. Electromyography of the limbs shows neurogenic changes. However, symptoms such as pseudohypertrophy of the gastrocnemius muscle and almost complete loss of motor function are rare, suggesting a poor prognosis.
conclusionThis rare case highlights that pseudohypertrophy of the gastrocnemius muscle may be a rare manifestation of type IV spinal muscular atrophy, and clinical differential diagnosis should be made with PMD and other diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.